Hydroxyapatite/beta-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorPeres, Maria F. S.
dc.creatorRibeiro, Erica D. P.
dc.creatorCasarin, Renato C. V.
dc.creatorRuiz, Karina G. S.
dc.creatorJunior, Francisco H. N.
dc.creatorSallum, Enilson A.
dc.creatorCasati, Marcio Z.
dc.date2014-12-03T13:08:56Z
dc.date2016-10-25T20:09:36Z
dc.date2014-12-03T13:08:56Z
dc.date2016-10-25T20:09:36Z
dc.date2013-03-01
dc.date.accessioned2017-04-06T06:15:53Z
dc.date.available2017-04-06T06:15:53Z
dc.identifierJournal Of Clinical Periodontology. Hoboken: Wiley-blackwell, v. 40, n. 3, p. 252-259, 2013.
dc.identifier0303-6979
dc.identifierhttp://hdl.handle.net/11449/111734
dc.identifierhttp://acervodigital.unesp.br/handle/11449/111734
dc.identifier10.1111/jcpe.12054
dc.identifierWOS:000314753600006
dc.identifierhttp://dx.doi.org/10.1111/jcpe.12054
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/922507
dc.descriptionObjective To clinically evaluate proximal furcations treated with hydroxyapatite/-tricalcium phosphate (HA/-TCP) isolated or combined with enamel matrix derivative (EMD). Material and Methods Thirty patients, presenting at least one proximal class II furcation defect, probing pocket depth (PPD) 5mm and bleeding on probing, were included. The defects were assigned to the HA/-TCP group (n=15); open-flap debridement (OFD)+HA/-TCP filling, or, HA/-TCP-EMD group (n=15); OFD+HA/-TCP+EMD filling. Plaque (PI) and gingival index (GI), PPD, relative gingival margin position (RGMP), vertical and horizontal attachment level (RVAL and RHAL), vertical and horizontal bone level (RVBL and RHBL), and furcation diagnosis were evaluated at baseline and at 6months. Results Both groups presented improvements after therapies (p<0.05); however, no inter-group differences could be seen in any single parameter (p>0.05). At 6months, the gains in rVCAL in the HA/-TCP and HA/-TCP-EMD groups were 1.47 +/- 0.99 and 2.10 +/- 0.87mm, while the RHCAL gains were 1.47 +/- 1.46 and 1.57 +/- 1.58mm (p>0.05). The RVBL and RHBL gains for the HA/-TCP and HA/-TCP-EMD group were 1.47 +/- 1.13 and 1.70 +/- 1.26mm, and 1.90 +/- 1.11 and 1.70 +/- 1.37mm respectively (p>0.05). The HA/-TCP-EMD group showed seven closed furcations versus four in the HA/-TCP group (p>0.05). Conclusion Both treatments lead to improvements in all clinical variables studied in the present trial. However, the closure of proximal class II furcation defects is still unpredictable.
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageeng
dc.publisherWiley-Blackwell
dc.relationJournal of Clinical Periodontology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectenamel matrix derivative
dc.subjecthydroxyapatite-beta tricalcium
dc.subjectphosphate
dc.subjectproximal furcation
dc.subjectregenerative therapy
dc.titleHydroxyapatite/beta-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial
dc.typeOtro


Este ítem pertenece a la siguiente institución